IGF2BP3 has been reported also as an oncogenic factor implicated in the transcription and splicing of MLL target genes in MLL-mAf4 mediated leukemia as its knockout impaired leukemogenesis in a mouse disease model31. This evidence concerns the gene IGF2BP3 and leukemia.